Last reviewed · How we verify

Epivir®, Retrovir® and Viramune®

Elim Pediatric Pharmaceuticals Inc. · Phase 1 active Small molecule

Epivir®, Retrovir® and Viramune® is a Small molecule drug developed by Elim Pediatric Pharmaceuticals Inc.. It is currently in Phase 1 development. Also known as: Lamivudine, Zidovudine, Nevirapine.

At a glance

Generic nameEpivir®, Retrovir® and Viramune®
Also known asLamivudine, Zidovudine, Nevirapine
SponsorElim Pediatric Pharmaceuticals Inc.
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Epivir®, Retrovir® and Viramune®

What is Epivir®, Retrovir® and Viramune®?

Epivir®, Retrovir® and Viramune® is a Small molecule drug developed by Elim Pediatric Pharmaceuticals Inc..

Who makes Epivir®, Retrovir® and Viramune®?

Epivir®, Retrovir® and Viramune® is developed by Elim Pediatric Pharmaceuticals Inc. (see full Elim Pediatric Pharmaceuticals Inc. pipeline at /company/elim-pediatric-pharmaceuticals-inc).

Is Epivir®, Retrovir® and Viramune® also known as anything else?

Epivir®, Retrovir® and Viramune® is also known as Lamivudine, Zidovudine, Nevirapine.

What development phase is Epivir®, Retrovir® and Viramune® in?

Epivir®, Retrovir® and Viramune® is in Phase 1.

Related